What is Proton Therapy
Read our Covid-19 policy

Call Now For More Information

General Questions or
Schedule an Appointment


Current Patients


Physician Line


Read our Covid-19 policy

Update on PCORI Breast Trial

Update on PCORI Breast Trial

The SCCA Proton Therapy Center is participating in a groundbreaking breast cancer trial with the Patient-Centered Outcomes Research Institute (PCORI).This is the first clinical trial designed to compare the effectiveness of proton beam therapy versus conventional photon radiation therapy for breast cancer. The trial is led by our own breast cancer radiation oncologist, L. Christine Fang, who was awarded the Athena Endowed Award for Excellence in Breast Cancer Research.

Currently enrolling patients, a coin-flip will decide which 50 percent of patients receive proton therapy and which 50 percent will receive photon treatment. This determines whether protons may provide a meaningful clinical benefit.

While conventional breast radiotherapy (X-rays or photons) has helped save many lives, the treatment can expose the heart, lungs, and other nearby tissue to excess radiation. This exposure can potentially lead to an increased risk of side effects, such as coronary artery disease. Proton therapy, on the other hand, directly targets the tumor while minimizing radiation exposure to the surrounding healthy tissue.

If you are suffering from breast cancer and require radiation, please visit https://www.seattlecca.org/clinical-trials/breast-cancer-NCT02603341 to learn if you qualify for the clinical trial, and let your doctor know if you’d like to participate.

For more information on receiving treatment at the SCCA Proton Therapy Center, please visit https://www.sccaprotontherapy.com/find-out-more/.